Trials / Recruiting
RecruitingNCT06555289
Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery
Visual and Refractive Outcomes of the Clareon PanOptix Pro IOL in Patients With Prior Myopic Refractive Surgery
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Juliette Eye Institute Research Center · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- —
Summary
This study is a Single center, single arm, prospective, observational study of clinical outcomes following bilateral cataract surgery and Clareon PanOptix Pro implantation. Subjects will be assessed preoperatively, and at 1 and 3 months postoperatively. Clinical evaluations will include administration of the QUVID and IOLSAT questionnaires, manifest refraction, topography, as well as measurement of visual acuities at distance, intermediate, and near.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Clareon PanOptix Pro IOL | Spherical and toric T3 |
Timeline
- Start date
- 2024-10-23
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2024-08-15
- Last updated
- 2025-12-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06555289. Inclusion in this directory is not an endorsement.